Intellectual property in a knowledge-based economy : Patents to include vs . patents to exclude

The traditional perception of patents puts the emphasis on their importance to exclude imitators and to restore incentives to invent. This view is far too restrictive and at variance with many empirical and theoretical works. We show that these contradictions can be overcome by shifting from a traditional economic framework to a knowledge-based one. Such a move allows a renewed economic perception of patents, making them into essential instruments which serve not only to exclude potential infringers but also to “include” all the different stakeholders in the innovation process. Within this new approach the main role of the patent system is therefore to ensure the coordination among heterogeneous actors and to structure innovation activities. We illustrate our view by presenting the four polar cases of pharmaceuticals, electronics, software and biotechnologies.

[1]  P. David.  Clio and the Economics of QWERTY , 1985 .

[2]  Rosemarie H. Ziedonis,et al.  The patent paradox revisited: an empirical study of patenting in the U , 2001 .

[3]  George A. Akerlof,et al.  The Market for “Lemons”: Quality Uncertainty and the Market Mechanism , 1970 .

[4]  Julien Pénin,et al.  Research Tool Patents and Free-Libre Biotechnology: A Unified Perspective , 2007 .

[5]  R. Nelson,et al.  The benefits and costs of strong patent protection: a contribution to the current debate , 1998 .

[6]  M. Reitzig.  What determines patent value?: Insights from the semiconductor industry , 2003 .

[7]  Michel Callon,et al.  Is Science a Public Good? Fifth Mullins Lecture, Virginia Polytechnic Institute, 23 March 1993 , 1994 .

[8]  P. David,et al.  Toward a new economics of science , 1994 .

[9]  E. von Hippel,et al.  Sources of Innovation , 2016 .

[10]  J. Hagedoorn.  Sharing intellectual property rights - an exploratory study of joint patenting amongst companies. , 2003 .

[11]  Malcolm Rowland,et al.  Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans , 2004, Pharmaceutical Research.

[12]  D. Teece,et al.  Managing Intellectual Capital: Licensing and Cross-Licensing in Semiconductors and Electronics , 1997 .

[13]  G. Hardin,et al.  The Tragedy of the Commons , 1968, Green Planet Blues.

[14]  M. Heller,et al.  Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.

[15]  A. Arundel.  The relative effectiveness of patents and secrecy for appropriation , 2001 .

[16]  Antoine Bureth,et al.  Modular Innovations and Distributed Processes. The Case of Genetically Engineered Vaccines , 2007 .

[17]  D. Foray,et al.  The Economics of Codification and the Diffusion of Knowledge , 1997 .

[18]  Josh Lerner,et al.  Tilting the Table? The Use of Preliminary Injunctions* , 2001, The Journal of Law and Economics.

[19]  Jean-Michel Dalle,et al.  Dynamiques d'adoption, coordination et diversité : la diffusion des standards technologiques. , 1995, Revue économique.

[20]  Paul A. David,et al.  The explicit economics of knowledge codification and tacitness , 2000 .

[21]  W. Arthur,et al.  INCREASING RETURNS AND LOCK-IN BY HISTORICAL EVENTS , 1989 .

[22]  William Kingston,et al.  Innovation needs patents reform , 2001 .

[23]  E. Mansfield.  Patents and Innovation: An Empirical Study , 1986 .

[24]  L. Lesko,et al.  Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans , 2000, Journal of clinical pharmacology.

[25]  K. Arrow.  Economic Welfare and the Allocation of Resources for Invention , 1962 .

[26]  S. Winter,et al.  An evolutionary theory of economic change , 1983 .

[27]  Nikolaus Thumm,et al.  Management of Intellectual Property Rights in European Biotechnology Firms , 2001 .

[28]  C. T. Taylor,et al.  The Economic Impact of the Patent System: A Study of the British Experience , 1973 .

[29]  Carl Shapiro,et al.  Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting , 2000, Innovation Policy and the Economy.

[30]  Janusz A. Ordover,et al.  A Patent System for Both Diffusion and Exclusion , 1991 .

[31]  A. Arundel,et al.  What percentage of innovations are patented? empirical estimates for European firms , 1998 .

[32]  Julien Pénin,et al.  Open Knowledge Disclosure: An Overview of the Evidence and Economic Motivations , 2007 .

[33]  Arvids A. Ziedonis,et al.  The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980 , 2001 .

[34]  Sidney G. Winter,et al.  Patents and Welfare in an Evolutionary Model , 1993 .

[35]  Ashish Arora,et al.  The Market for Technology in the Chemical Industry : Causes and Consequences , 2000 .

[36]  E. Mansfield,et al.  Imitation Costs and Patents: An Empirical Study , 1981 .

[37]  B. Sampat,et al.  University patenting : an assessment of the causes and consequences of recent changes in strategies and practices , 2002 .

[38]  S. Winter,et al.  An Evolutionary Theory of Economic Change.by Richard R. Nelson; Sidney G. Winter , 1987 .

[39]  J. Hagedoorn.  Inter-firm R&D partnerships: an overview of major trends and patterns since 1960 , 2002 .

[40]  A. Jaffe.  The U.S. patent system in transition: policy innovation and the innovation process , 2000 .

[41]  Raja Attia,et al.  Innovative Labor and Intellectual Property Market in the Semiconductor Industry , 2001 .

[42]  J. Mahlich,et al.  The changing nature of pharmaceutical R&D : opportunities for Asia? , 2001 .

[43]  F. Scherer,et al.  The Economic Impact of the Patent System. , 1975 .

[44]  Deepak Somaya.  Strategic determinants of decisions not to settle patent litigation , 2003 .

[45]  D. North.  Competing Technologies , Increasing Returns , and Lock-In by Historical Events , 1994 .

[46]  D. Harhoff,et al.  Determinants of Opposition against EPO Patent Grants – The Case of Biotechnology and Pharmaceuticals ∗ , 2002 .

[47]  Arvids A. Ziedonis,et al.  Academic patent quality and quantity before and after the Bayh-Dole act in the United States , 2002 .

[48]  Benjamin Coriat,et al.  Establishing a new intellectual property rights regime in the United States: Origins, content and problems , 2002 .

[49]  Walter W. Powell,et al.  Inter-Organizational Collaboration in the Biotechnology Industry , 1996 .

[50]  D. Foray,et al.  L'conomie du logiciel libre. Organisation cooprative et incitation l'innovation , 2001 .

[51]  Haiyang Zhang,et al.  What is Behind the Recent Surge in Patenting in China , 2010 .

[52]  S. Winter,et al.  Appropriating the Returns from Industrial Research and Development , 1987 .

[53]  Julien Pénin,et al.  Open knowledge disclosure, incomplete information and collective innovations , 2005 .

[54]  Adam B. Jaffe,et al.  Innovation and its Discontents , 2004 .

[55]  Joshua Lerner,et al.  Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do About It , 2011 .

[56]  Antoine Bureth,et al.  Brevet, innovation modulaire et collaboration. Le cas des vaccins géniques , 2007 .

[57]  Dominique Foray,et al.  L'économie du logiciel libre , 2001 .

[58]  A. Arora,et al.  Markets for Technology: The Economics of Innovation and Corporate Strategy , 2004 .